Akari Therapeutics announced that its Head of Oncology, Satyajit Mitra, will present their innovative RNA-splicing antibody drug conjugate (ADC) payload strategy at the 3rd Annual ADC Payload Summit in November 2026. This novel approach uses the PH1 payload to disrupt RNA splicing in cancer cells, combining direct tumor cell killing with immune system activation, potentially offering advantages over traditional ADCs. Their lead candidate, AKTX-101, targets the Trop2 receptor and has shown promising preclinical results, including synergy with immunotherapies. Akari plans to start first-in-human trials by mid-2027, aiming to advance next-generation ADC therapies for cancer treatment.
Akari Therapeutics' novel RNA-splicing ADC payload strategy is the subject of this update. For readers following the Health sector, here is Pluang's market snapshot as of Oct 30, 2026 20:21 WIB: Of 150 priced Health-sector US stocks tradable on Pluang, 71 rose and 76 fell today. Notable movers include MRVI at USD 7.95 with a -6.03% change and a typical hold time of 11 days, AZN at USD 183.80 with a +5.39% change and Pluang order activity of 86% Sell / 14% Buy, and TXG at USD 77.33 with a -5.17% change and Pluang order activity of 52% Sell / 48% Buy.
FreightCar America disclosed on October 19, 2026, that it removed 1,285 railcars from its backlog after a customer was unlikely to fulfill contractual obligations, causing its stock to drop 31.4% to $4.02. This sharp decline has led Glancy Prongay Wo...
FirstCash Holdings, Inc. shares fell 14.75% following the October 22, 2026 disclosure of its third quarter financial results, which showed a 28% year-over-year decline in operating income for its American First Finance segment to $33 million. The com...
The global screw compressors market is projected to grow from $13.97 billion in 2026 to $18.38 billion by 2031, at a CAGR of 5.66%. Growth is fueled by rising industrial automation, energy-efficiency regulations, and demand in manufacturing, oil and ...
Enova International's stock fell 23.43% after the company withdrew its application to acquire Grasshopper Bancorp and become a bank holding company. The withdrawal was due to unclear regulatory standards and political pressures cited by Enova. This s...
The global dialysis machines market is forecasted to grow from $17.89 billion in 2026 to $31.54 billion by 2035, at a CAGR of 6.5%. Growth is fueled by rising chronic kidney disease cases, expanding dialysis infrastructure, and innovations like home ...
